Regulation of calcium signaling in dendritic cells by 1,25‐dihydroxyvitamin D₃

Banchereau J., 2000, Immunobiology of dendritic cells, Annu. Rev. Immunol., 18, 767, 10.1146/annurev.immunol.18.1.767

Den Haan J. M., 2000, A novel helper role for CD4 T cells, Proc. Natl. Acad. Sci. U. S. A., 97, 12950, 10.1073/pnas.97.24.12950

Steinman R. M., 2002, Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance, Proc. Natl. Acad. Sci. U. S. A., 99, 351, 10.1073/pnas.231606698

Yamazaki S., 2009, Dendritic cells as controllers of antigen‐specific Foxp3+ regulatory T cells, J. Dermatol. Sci., 54, 69, 10.1016/j.jdermsci.2009.02.001

Connolly S. F., 2007, The regulation of dendritic cell function by calcium‐signaling and its inhibition by microbial pathogens, Immunol. Res., 39, 115, 10.1007/s12026-007-0076-1

Hsu S., 2001, Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway, J. Immunol., 166, 6126, 10.4049/jimmunol.166.10.6126

Parekh A. B., 2005, Store‐operated calcium channels, Physiol. Rev., 85, 757, 10.1152/physrev.00057.2003

Vukcevic M., 2008, Ryanodine receptor activation by Cav1.2 is involved in dendritic cell major histocompatibility complex class II surface expression, J. Biol. Chem., 283, 34913, 10.1074/jbc.M804472200

Barbet G, 2008, The calcium‐activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells, Nat. Immunol., 9, 1148, 10.1038/ni.1648

Berridge M. J., 2003, Calcium signalling: dynamics, homeostasis and remodelling, Nat. Rev. Mol. Cell. Biol., 4, 517, 10.1038/nrm1155

Berridge M.J., 2006, Calcium microdomains: organization and function, Cell Calcium, 40, 405, 10.1016/j.ceca.2006.09.002

Clapham D. E., 2007, Calcium signaling, Cell, 131, 1047, 10.1016/j.cell.2007.11.028

Visser F., 2007, K+‐dependent Na+/Ca2+ exchangers: key contributors to Ca2+ signaling, Physiology (Bethesda), 22, 185

Visser F., 2007, Exchangers NCKX2, NCKX3, and NCKX4: identification of Thr‐551 as a key residue in defining the apparent K+ affinity of NCKX2, J. Biol. Chem., 282, 4453, 10.1074/jbc.M610582200

Blaustein M. P., 1999, Sodium/calcium exchange: its physiological implications, Physiol. Rev., 79, 763, 10.1152/physrev.1999.79.3.763

Lytton J., 2007, Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport, Biochem. J., 406, 365, 10.1042/BJ20070619

Herchuelz A., 2007, Role of Na/Ca exchange and the plasma membrane Ca2+‐ATPase in β cell function and death, Ann. N. Y. Acad. Sci., 1099, 456, 10.1196/annals.1387.048

Staiano R. I., 2009, Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes, Eur. J. Immunol., 39, 1405, 10.1002/eji.200838792

Ramasamy I., 2006, Recent advances in physiological calcium homeostasis, Clin. Chem. Lab. Med., 44, 237, 10.1515/CCLM.2006.046

Cantorna M. T., 2004, Vitamin D status, 1,25‐dihydroxyvitamin D3, and the immune system, Am. J. Clin. Nutr., 80, 1717S, 10.1093/ajcn/80.6.1717S

DeLuca H. F., 2001, Vitamin D: its role and uses in immunology, FASEBJ., 15, 2579, 10.1096/fj.01-0433rev

Zehnder D., 1999, The renal function of 25‐hydroxyvitamin D3‐1α‐hydroxylase, Mol. Cell. Endocrinol., 151, 213, 10.1016/S0303-7207(99)00039-8

Heine G., 2008, 1,25‐Dihydroxyvitamin D3 promotes IL‐10 production in human B cells, Eur. J. Immunol., 38, 2210, 10.1002/eji.200838216

Hewison M., 2003, Differential regulation of vitamin D receptor and its ligand in human monocyte‐derived dendritic cells, J. Immunol., 170, 5382, 10.4049/jimmunol.170.11.5382

Hewison M., 2003, Vitamin D‐mediated hypercalcemia in lymphoma: evidence for hormone production by tumor‐adjacent macrophages, J. Bone Miner. Res., 18, 579, 10.1359/jbmr.2003.18.3.579

Fritsche J., 2003, Regulation of 25‐hydroxyvitamin D3‐1α‐hydroxylase and production of 1α,25‐dihydroxyvitamin D3 by human dendritic cells, Blood, 102, 3314, 10.1182/blood-2002-11-3521

Adorini L., 2004, Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands, J. Steroid Biochem. Mol. Biol., 89, 437, 10.1016/j.jsbmb.2004.03.013

Yu S., 2008, The vitamin D receptor is required for iNKT cell development, Proc. Natl. Acad. Sci. U. S. A., 105, 5207, 10.1073/pnas.0711558105

Gauzzi M. C., 2005, Suppressive effect of 1α,25‐dihydroxyvitamin D3 on type I IFN‐mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis, J. Immunol., 174, 270, 10.4049/jimmunol.174.1.270

Lyakh L. A., 2005, TGF‐β and vitamin D3 utilize distinct pathways to suppress IL‐12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells, J. Immunol., 174, 2061, 10.4049/jimmunol.174.4.2061

Penna G., 2007, 1,25‐Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells, J. Immunol., 178, 145, 10.4049/jimmunol.178.1.145

Van Etten E., 2005, Immunoregulation by 1,25‐dihydroxyvitamin D3: basic concepts, J. Steroid Biochem. Mol. Biol., 97, 93, 10.1016/j.jsbmb.2005.06.002

Imazeki I., 2006, Immunomodulating effect of vitamin D3 derivatives on type‐1 cellular immunity, Biomed. Res., 27, 1, 10.2220/biomedres.27.1

Griffin M. D., 2007, Vitamin D receptor‐mediated suppression of RelB in antigen presenting cells: a paradigm for ligand‐augmented negative transcriptional regulation, Arch. Biochem. Biophys., 460, 218, 10.1016/j.abb.2007.01.034

Szeles L., 2009, 1,25‐Dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype, J. Immunol., 182, 2074, 10.4049/jimmunol.0803345

Lemire J. M., 1991, 1,25‐Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis, J. Clin. Invest., 87, 1103, 10.1172/JCI115072

Cantorna M. T., 1996, 1,25‐Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis, Proc. Natl. Acad. Sci. U. S. A., 93, 7861, 10.1073/pnas.93.15.7861

Cantorna M. T., 1999, Dietary calcium is a major factor in 1,25‐dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice, J. Nutr., 129, 1966, 10.1093/jn/129.11.1966

Becklund B. R. Hansen D. W.Jr. andDeLuca H. F.(2009)Enhancement of 1 25‐dihydroxyvitamin D3‐mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.Proc. Natl. Acad. Sci. U. S. A.

Hamill O. P., 1981, Improved patch‐clamp techniques for high‐resolution current recording from cells and cell‐free membrane patches, Pflügers Arch., 391, 85, 10.1007/BF00656997

Matzner N., 2008, Ion channels modulating mouse dendritic cell functions, J. Immunol., 181, 6803, 10.4049/jimmunol.181.10.6803

Lambers T. T., 2006, Coordinated control of renal Ca2+ handling, Kidney Int., 69, 650, 10.1038/sj.ki.5000169

Rogister F., 2001, Novel inhibitors of the sodiumcalcium exchanger: benzene ring analogues of N‐guanidino substituted amiloride derivatives, Eur. J. Med. Chem., 36, 597, 10.1016/S0223-5234(01)01247-8

Aneiros E., 2005, Modulation of Ca2+ signaling by Na+/Ca2+ exchangers in mast cells, J. Immunol., 174, 119, 10.4049/jimmunol.174.1.119

Reppel M., 2007, Regulation of Na+/Ca2+ exchange current in the normal and failing heart, Ann. N. Y. Acad. Sci., 1099, 361, 10.1196/annals.1387.065

Sipido K. R., 2007, Na/Ca exchange and cardiac ventricular arrhythmias, Ann. N Y. Acad. Sci., 1099, 339, 10.1196/annals.1387.066

Venetucci L. A., 2007, Na/Ca exchange: regulator of intracellular calcium and source of arrhythmias in the heart, Ann. N. Y. Acad. Sci., 1099, 315, 10.1196/annals.1387.033

Canitano A., 2002, Brain distribution of the Na+/Ca2+ exchanger‐encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system, Ann. N. Y. Acad. Sci., 976, 394, 10.1111/j.1749-6632.2002.tb04766.x

Schmitt R., 1999, Developmental expression of sodium entry pathways in rat nephron, Am. J. Physiol., 276, F367

Kimura M., 1999, Physiological and molecular characterization of the Na+/Ca2+ exchanger in human platelets, Am. J. Physiol., 277, H911

Balasubramanyam M., 1994, Na+/Ca2+ exchange‐mediated calcium entry in human lymphocytes, J. Clin. Invest., 94, 2002, 10.1172/JCI117553

Tintinger G. R., 2004, Counteracting effects of NADPH oxidase and the Na+/Ca2+ exchanger on membrane repolarisation and store‐operated uptake of Ca2+ by chemoattractant‐activated human neutrophils, Biochem. Pharmacol., 67, 2263, 10.1016/j.bcp.2004.02.029

Rumpel E., 2000, Na+‐dependent Ca2+ transport modulates the secretory response to the Fcε receptor stimulus of mast cells, Biophys. J., 79, 2975, 10.1016/S0006-3495(00)76534-9

Herrmann T. L., 2007, MHC class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II, J. Leukoc. Biol., 82, 686, 10.1189/jlb.0107045

Koski G. K., 1999, Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell‐like characteristics through discrete signaling pathways, J. Immunol., 163, 82, 10.4049/jimmunol.163.1.82

Aki D., 2008, Peptidoglycan and lipopolysaccharide activate PLCγ/2, leading to enhanced cytokine production in macrophages and dendritic cells, Genes Cells, 13, 199, 10.1111/j.1365-2443.2007.01159.x

Bellou A., 2005, Costimulation: critical pathways in the immunologic regulation of asthma, Curr. Allergy Asthma Rep., 5, 149, 10.1007/s11882-005-0089-6

Choy E. H., 2009, Selective modulation of T‐cell co‐stimulation: a novel mode of action for the treatment of rheumatoid arthritis, Clin. Exp. Rheumatol., 27, 510

Korhonen R., 2009, Abatacept, a novel CD80/86‐CD28 T cell co‐stimulation modulator, in the treatment of rheumatoid arthritis, Basic Clin. Pharmacol. Toxicol., 104, 276, 10.1111/j.1742-7843.2009.00375.x

Lagana B., 2009, Modulation of T‐cell co‐stimulation in rheumatoid arthritis: clinical experience with abatacept, Clin. Drug Investig., 29, 185, 10.2165/00044011-200929030-00005